Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

926 Results

Document

OCS2024-Excel-workbook-Figures-Fr-3-27.xlsx

Mar 2025

Document

OCS2024-Excel-workbook-Figures-Fr-3-27-25.xlsx

Mar 2025

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Document

OvarianBorderlineLMPTreatmentPathwayMap.pdf

Apr 2025

Document

OvarianCancerDiagnosisPathwayMap.pdf

Apr 2025

Drug

atezolizumab (subcut)

Other Name(s): Tecentriq® SC

Quick Link(s): Drug Monograph, Patient Info Sheet

Jul 2025

Regimen

AVD+NIVL

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Show More Show more tags

, Show Less Show fewer tags

Intent: Curative

Drugs Used:

nivolumab (Unfunded),

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

May 2025

Document

Accompagnement-dans-votre-parcours-de-soins-palliatifs.pdf

New

Jun 2025

Document

OH-Cancer-Poster-FN-Ojibwe-Eastern-print.pdf

New

Jun 2025

Document

OH-Cancer-Poster-FN-Ojibwe-Southern-print.pdf

New

Jun 2025

Document

OH-Cancer-Postcard-FN-Ojibwe-Southern-print.pdf

New

Jun 2025

Document

OH-Cancer-Postcard-FN-Ojibwe-Eastern-print.pdf

New

Jun 2025

Pages